𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication

✍ Scribed by Anne Rogers; Jenny Day; Fiona Randall; RichardP. Bentall


Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
228 KB
Volume
38
Category
Article
ISSN
1433-9285

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Background, rationale, and design of a c
✍ Sherrill J. Slichter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Outlined is the background and rationale for the initiation of a randomized prospective platelet transfusion trial to evaluate the effects of platelet dose on hemostasis and platelet utilization rates. This clinical trial is being performed by the newly established Transfusion Medicine/

INSPIRE study: Does stress management im
✍ Birgitte Boye; Knut E.A. Lundin; Günter Jantschek; Siv Leganger; Kjell Mokleby; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

Background: The use of stress management psychotherapy is hypothesized to produce greater improvement in disease course and disease-specific quality of life (IBDQ) compared to usual medical care alone in patients with ulcerative colitis (UC) or Crohn's disease (CD) showing high levels of stress (bas

Rapid and sustained improvement in bone
✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa

Fractionated cyclophosphamide and back t
✍ Brecher, Martin L.; Schwenn, Molly R.; Coppes, Max J.; Bowman, W. Paul; Link, Mi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Background: The pediatric oncology group (pog) conducted a two-arm, randomized study for the treatment of children and adolescents with stage iii small, non-cleaved cell lymphoma (snccl). regimen a, based on the group's previous best treatment for this group of patients, included cyclophosphamid